| |
Newsroom /
Health and Fitness
/
Health and Fitness
/
Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators
Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators
Pharmaceutical Companies Looking at Innovative Drug Delivery Systems to Enhance Their Products - CNS, Gastrointestinal and Hormone and Related Agents are the Focused Therapeutic Areas Using Drug Delivery Systems
Hyderabad,
AP,
India
(prbd.net)
14/10/2010
"Controlled and Sustained Release to be Major Revenue Generators"
Over the last few years, the pharmaceutical industry has seen patent expiries for major blockbuster drugs which have resulted in losses worth billions. More blockbuster drugs are about to lose patent in the coming years. In such a situation, pharmaceutical companies are increasingly adopting various drug delivery systems to enhance their product efficacy, patient compliance and extend patent lives through innovative repositioning and reformulations of existing drugs. This has resulted in significant growth in the drug delivery market over the last few years. According to GBI Research, the overall drug delivery market is forecasted to grow to to $199 billion in 2016 from $101 billion in 2009, at a CAGR of 10.3%.
Central Nervous System (CNS) agents, hormone-related agents and gastrointestinal agents are among the key therapeutic areas witnessing the use of innovative drug delivery methods, and this trend is expected to grow in the coming years.
For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Oral-Drug-Delivery-Market-Controlled-and-Sustained-Release-to-be-Major-Revenue-Generators&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare
The oral drug delivery market remains the largest segment of the overall drug delivery market, with more than 52% of the market share. It is presently valued at $49 billion and is expected to reach $92 billion by 2016, at a CAGR of 11.3%. The growth in the oral drug delivery market shall be driven primarily by newer technologies enabling controlled release formulations of oral drugs and oral formulations of injectible only drugs
.
Other innovative technologies like nanotechnology-enabled oral drugs and oral forms of prodrugs have also seen significant research and development over the past few years, both in academic circles as well as in the industry as a whole.
Innovative oral formulations like orally disintegrating tablets, fast dissolving tablets and mini-tablets have been introduced into the market, which ensure better patient compliance, reduce dosage frequencies and enable customizable drug loading.
GBI Research’s report, “Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators”, provides in-depth analysis of the unmet needs, drivers and barriers that impact the global oral drug delivery market. The report analyzes the markets for oral drug delivery systems in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for these key geographies, as well as for the market’s leading therapeutic segments. The report provides competitive benchmarking for the leading companies in the market and analyzes the mergers, acquisitions and licensing agreements that shape the global oral drug delivery market.
For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Oral-Drug-Delivery-Market-Controlled-and-Sustained-Release-to-be-Major-Revenue-Generators&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare
Visit our report store: http://www.gbiresearch.com
For more details contact:
pressreleases@gbiresearch.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782
About
GlobalData is a global market intelligence services company providing information research and analysis products and services.
|